1-5 of 5
Jaques-Emmanuel Galimard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group

Maria Carmen Martinez Munoz, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Herve Ghesquieres, Luc-Matthieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, A. Burhan Ferhanoglu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso De Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda Balari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2024-205007
Published: 2024
Journal Articles

No Differences in Transplant Outcomes with Post-Transplant Cyclophosphamide in One Antigen Mismatched Unrelated Donor Compared to Matched Unrelated Donor Recipients Receiving Antithymocyte Globulin in Patients with Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Giorgia Battipaglia, Allain Thibeault Ferhat Berland, Jaques-Emmanuel Galimard, Myriam Labopin, Didier Blaise, Jan Vydra, Claude-Éric Bulabois, Alexander Kulagin, Franca Fagioli, Thomas Schroeder, Igor Wolfgang Blau, Nicolaus Kröger, Urpu Salmenniemi, Laimonas Griskevicius, Annalisa Ruggeri, Simona Piemontese, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2024) 144 (Supplement 1): 693.
https://doi.org/10.1182/blood-2024-203472
Published: 2024
Journal Articles

Prognostic Impact of t(9;11) and Del(7q) As Intermediate-Risk Abnormalities in AML Following Allo-Transplant: Insights from the ELN 2022 Classification - an EBMT ALWP Study

Iman Abou Dalle, Jaques-Emmanuel Galimard, Ali Bazarbachi, Gerard Socie, Patrice Chevallier, Peter Dreger, Gitte Olesen, Ibrahim Yakoub-Agha, Jurjen Versluis, Jurgen Kuball, Igor Wolfgang Blau, Hélène Labussière-Wallet, Thomas Heinicke, Dominik Schneidawind, Tobias A.W. Holderried, Keith Wilson, Thomas Schroeder, Frederic Baron, Eolia Brissot, Jordi Esteve, Arnon Nagler, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2024) 144 (Supplement 1): 4945.
https://doi.org/10.1182/blood-2024-204824
Published: 2024
Journal Articles

Pre-Transplant Somatic Co-Occurring Mutations (by next generation sequencing) in Acute Myeloid Leukemia: Frequency and Impact on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation - a Large Study on Behalf of the EBMT Acute Leukemia Working Party

Ali Bazarbachi, Jaques-Emmanuel Galimard, Myriam Labopin, Iman Abou Dalle, Jaime Sanz, He Huang, Jiri Mayer, Carlos Solano, Celestine Simand, Laimonas Griskevicius, Johan Maertens, Maija Itäla-remes, Ain Kaare, Maria Pilar Gallego Hernanz, Gesine Bug, Josep-Maria Ribera, Alain Gadisseur, Christoph Schmidt, Mi Kwon, Xavier Poire, Paola Coccia, Manuel Jurado Chacón, Frederic Baron, Eolia Brissot, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 657.
https://doi.org/10.1182/blood-2023-182823
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Jaime Sanz, MD PhD, Jaques-Emmanuel Galimard, Boris V Afanasyev, MD PhD professor, Emanuele Angelucci, MD, Fabio Ciceri, MD, Didier Blaise, MD PhD, Jan J Cornelissen, MD PhD, Ellen Meijer, MD PhD, José Luis Díez-Martín, MD PhD, Yener Koc, MD, Montserrat Rovira, Luca Castagna, MD, Bipin N. Savani, MD, Annalisa Ruggeri, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3274.
https://doi.org/10.1182/blood-2019-125859
Published: 2019